ArticleFrontiers in medicine2026
Prognostic factors for cardiovascular-related mortality in pediatric hypertrophic cardiomyopathy: a retrospective cohort study with survival analysis and X-tile stratification.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To identify prognostic factors associated with cardiovascular-related mortality in children with hypertrophic cardiomyopathy (HCM) and to explore outcome-oriented risk stratification using optimal cut-off values for continuous variables. Methods: This retrospective cohort study included 41 children diagnosed with HCM at The First Affiliated Hospital of Guangxi Medical University between January 1, 2013, and October 1, 2024. Baseline demographic characteristics, clinical manifestations, chest radiographic findings, electrocardiographic features, echocardiographic parameters, and serum biochemical indices were collected. Cardiovascular-related mortality was defined as the primary endpoint, with follow-up censored at the last clinical contact for patients lost to follow-up. Univariate Cox proportional hazards regression was performed to screen variables associated with mortality. Optimal cut-off values for continuous variables were determined using X-tile software, followed by Kaplan-Meier survival analysis and log-rank testing to compare survival differences between risk strata. Results: Univariate Cox analysis showed no significant associations between baseline categorical clinical variables and cardiovascular-related mortality, with only a borderline sex-related difference observed. In contrast, several echocardiographic parameters were significantly associated with mortality. Increased left ventricular end-diastolic diameter (LVEDd) (HR = 1.084, Conclusion: This single-center real-world cohort suggests that cardiovascular-related mortality in pediatric HCM is more consistently associated with echocardiographic indicators reflecting left ventricular remodeling, hypertrophic burden, and systolic function, as well as biochemical markers of myocardial injury and metabolic stress. X-tile-based stratification of continuous variables provides intuitive and potentially actionable risk thresholds for intra-cohort follow-up and early risk warning. However, the generalizability of these thresholds requires validation in larger, multicenter cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.